Report: Medtronic helped draft, edit medical journal articles
A US Senate Finance Committee report alleges that Medtronic was heavily involved in drafting, editing and shaping the content of medical journal articles authored by its physician consultants involving its InFuse bone growth product used in spine surgery. This information was not disclosed, raising serious questions about the research conducted. Medtronic was paid $210 million over several years through royalties and consulting fees.
- mHealth Tackles Readmissions
- 'Kafkaesque' Value System Unfairly Penalizes Doctor Pay
- CNO Leads $1M Charge for New Scrubs, Uniforms
- Targeting Self-Insured Populations
- MA an Insurance Proving Ground for Providers
- Proton Beam Therapy Poised for Growth in US
- Sharp HealthCare Leaves Pioneer ACO Program
- Some Cancer Hospitals' Quality Data Will Soon Be Public
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Docs Fret as HHS Addresses Malpractice Reporting 'Loopholes'